PeptadexPEPTADEX
Back to Library

Thymosin Alpha-1

Also known as: Ta1, Zadaxin

ImmunePHASE 3

Clinical Status

Approved in 35+ countries — not FDA approved in US.

Mechanism of Action

Modulates T-cell function, enhances dendritic cell maturation, and promotes Th1 immune responses. Increases IL-2, interferon-alpha, and interferon-gamma production.

Dosing Defaults

Dose

1.6 mg

Frequency

2-3x weekly

Administration

Subcutaneous injection

Timing

Morning

Food

with or without

Duration

6-12 months

Dose range: 0.8-3.2 mg per dose

Morning dosing supports immune system activation during waking hours.

Side Effects

  • •Injection site reactions
  • •Mild fatigue
  • •Headache
  • •Rare allergic reactions

Contraindications & Warnings

  • ⚠Immunosuppressed transplant patients
  • •Not medical advice

Compare

Compare Thymosin Alpha-1 with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your Thymosin Alpha-1 dose.

Open Calculator

Ad

Related Immune Peptides

LL-37

PHASE 1
Immune

Antimicrobial peptide with broad-spectrum activity and wound healing properties.

KPV

PRECLINICAL
Immune

Anti-inflammatory peptide fragment. Does NOT cause immunosuppression.

VIP

PHASE 2
Immune

Immunomodulatory peptide used in mold illness (CIRS) protocols.

Thymulin

PRECLINICAL
Immune

Zinc-dependent thymic peptide that promotes T-cell maturation and immune balance.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.